BIOMIND LABS INC. Cash Flow-to-Debt Ratio
BIOMIND LABS INC. cash flow-to-debt ratio. BIOMIND LABS INC. (3XI) has a Cash Flow-to-Debt Ratio of -0.02x as of September 2025, meaning its operating cash flow of €-38.70K could theoretically repay 0% of its total liabilities (€1.62 Million) in one year. Check BIOMIND LABS INC. cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of BIOMIND LABS INC. (2021–2024)
Cash flow-to-debt ratio of BIOMIND LABS INC. from 2021 to 2024. Historical debt coverage capacity for BIOMIND LABS INC. across 4 annual periods. Check cash flow quality index of BIOMIND LABS INC. to evaluate the quality of earnings relative to operating cash generation.
BIOMIND LABS INC. Cash Flow-to-Debt Ratio by Year (2021–2024)
BIOMIND LABS INC. cash flow-to-debt ratio by year from 2021 to 2024. Year-by-year debt coverage analysis for BIOMIND LABS INC.. For the full cash flow conversion analysis, see 3XI cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.26x | €-354.43K | €1.34 Million | ▲ +48.0% |
| 2023 | -0.51x | €-765.93K | €1.51 Million | ▲ +92.0% |
| 2022 | -6.39x | €-2.15 Million | €336.72K | ▼ -0.8% |
| 2021 | -6.34x | €-2.12 Million | €334.95K | — |